Histone deacetylase inhibitor LAQ824 down-regulates Her-2 and sensitizes human breast cancer cells to trastuzumab, taxotere, gemcitabine, and epothilone B

L Fuino, P Bali, S Wittmann, S Donapaty, F Guo… - Molecular cancer …, 2003 - AACR
Histone deacetylase inhibitors induce hyperacetylation of the amino-terminal lysine residues
of the core nucleosomal histones, which results in chromatin remodeling and altered gene …

[PDF][PDF] Histone deacetylase inhibitor LAQ824 down-regulates Her-2 and sensitizes human breast cancer cells to trastuzumab, taxotere, gemcitabine, and epothilone B

L Fuino, P Bali, S Wittmann, S Donapaty, F Guo… - scholar.archive.org
Histone deacetylase inhibitors induce hyperacetylation of the amino-terminal lysine residues
of the core nucleosomal histones, which results in chromatin remodeling and altered gene …

[PDF][PDF] Histone deacetylase inhibitor LAQ824 down-regulates Her-2 and sensitizes human breast cancer cells to trastuzumab, taxotere, gemcitabine, and epothilone B

L Fuino, P Bali, S Wittmann, S Donapaty, F Guo… - Citeseer
Histone deacetylase inhibitors induce hyperacetylation of the amino-terminal lysine residues
of the core nucleosomal histones, which results in chromatin remodeling and altered gene …

Histone deacetylase inhibitor LAQ824 down-regulates Her-2 and sensitizes human breast cancer cells to trastuzumab, taxotere, gemcitabine, and epothilone B

L Fuino, P Bali, S Wittmann… - Molecular cancer …, 2003 - pubmed.ncbi.nlm.nih.gov
Histone deacetylase inhibitors induce hyperacetylation of the amino-terminal lysine residues
of the core nucleosomal histones, which results in chromatin remodeling and altered gene …

Histone deacetylase inhibitor LAQ824 down-regulates Her-2 and sensitizes human breast cancer cells to trastuzumab, taxotere, gemcitabine, and epothilone B

L Fuino, P Bali, S Wittmann… - Molecular cancer …, 2003 - mdanderson.elsevierpure.com
Histone deacetylase inhibitors induce hyperacetylation of the amino-terminal lysine residues
of the core nucleosomal histones, which results in chromatin remodeling and altered gene …

[引用][C] Histone deacetylase inhibitor LAQ824 down-regulates Her-2 and sensitizes human breast cancer cells to trastuzumab, taxotere, gemcitabine, and epothilone B

L FUINO - Mol Cancer Ther., 2003 - cir.nii.ac.jp
Histone deacetylase inhibitor LAQ824 down-regulates Her-2 and sensitizes human breast
cancer cells to trastuzumab, taxotere, gemcitabine, and epothilone B | CiNii Research CiNii 国立 …

[PDF][PDF] Histone deacetylase inhibitor LAQ824 down-regulates Her-2 and sensitizes human breast cancer cells to trastuzumab, taxotere, gemcitabine, and epothilone B

L Fuino, P Bali, S Wittmann, S Donapaty, F Guo… - researchgate.net
Histone deacetylase inhibitors induce hyperacetylation of the amino-terminal lysine residues
of the core nucleosomal histones, which results in chromatin remodeling and altered gene …

Histone deacetylase inhibitor LAQ824 down-regulates Her-2 and sensitizes human breast cancer cells to trastuzumab, taxotere, gemcitabine, and epothilone B.

L Fuino, P Bali, S Wittmann, S Donapaty… - Molecular Cancer …, 2003 - europepmc.org
Histone deacetylase inhibitors induce hyperacetylation of the amino-terminal lysine residues
of the core nucleosomal histones, which results in chromatin remodeling and altered gene …

Histone deacetylase inhibitor LAQ824 down-regulates Her-2 and sensitizes human breast cancer cells to trastuzumab, taxotere, gemcitabine, and epothilone B

L Fuino, P Bali, S Wittmann, S Donapaty… - Molecular cancer …, 2003 - pure.psu.edu
Histone deacetylase inhibitors induce hyperacetylation of the amino-terminal lysine residues
of the core nucleosomal histones, which results in chromatin remodeling and altered gene …